MPNRF | November 6, 2019
Two new clinical trials available for MPN patients
Click here to learn more about current clinical trials for PV, ET, and MF patients.
Vactosertib
This is a 2-tiered, Phase 2, Rule-based, Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib (TEW-7197) in the Treatment of Anemic Patients With Philadelphia Chromosome-negative MPNs (Ph-neg MPNs). Read the full description here
Status: Not yet recruiting
PRT543
This is a Phase 1 cohort, dose-escalation study of PRT543 inpatients with advanced cancers who have exhausted available treatment options. The purpose of this study is to define a safe dose andschedule to be used in the development of PRT543.
Read the full
description here
Status: Recruiting
